Picture of Synergy CHC logo

SNYRQ — Synergy CHC News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Synergy CHC Corp reports results for the quarter ended December 31 - Earnings Summary

Synergy CHC Corp SNYR.OQ reported quarterly adjusted earnings of 1 cent​​ per share for the quarter ended December 31.  The lone analyst forecast for the quarter was for earnings of 10 cents per share.

Revenue was $10.27 million​; analysts expected $323.12 thousand.

Synergy CHC Corp's reported EPS for the quarter was 1 cent​.

The company reported quarterly net income of $106 thousand.

Synergy CHC Corp shares had fallen by 34.1% this quarter.

FORECAST CHANGES

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"

Wall Street's median 12-month price target for Synergy CHC Corp is $10.00

This summary was machine generated from LSEG data March 31 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDINGESTIMATEACTUALBEAT, MET, MISSED
Dec. 31 20240.100.01Missed

Recent news on Synergy CHC

See all news